文献速递呼吸道感染

支气管扩张症「频繁急性加重表型」的特征分析

Characterization of the "Frequent Exacerbator Phenotype" in Bronchiectasis.
PubMed 文献 · Am J Respir Crit Care Med · 2018-01-01

研究纳入欧洲和以色列10个中心的2572例支气管扩张症患者,随访长达5年,按基线年急性加重次数(0、1、2、≥3次)分组。频繁急性加重是未来急性加重频率的最强预测因素,提示存在一致的表型;频繁加重者生活质量更差、住院更多、死亡率随加重频率增加而升高。

要点

  • 频繁急性加重是支气管扩张症未来加重频率的最强预测因素,表型稳定。
  • 基线年加重≥3次者未来加重发生率比为5.97(95%CI 5.27-6.78)。
  • 频繁加重者生活质量更差、住院更多,随访死亡率随加重频率增加而升高。

核心结论

  • 支气管扩张症存在稳定的频繁急性加重表型,该表型与疾病严重度高、生活质量差及随访期间死亡率增加相关。

研究设计与样本

  • 多中心队列研究,纳入欧洲和以色列10个临床中心的2572例支气管扩张症患者,随访长达5年,按基线年急性加重频率(0、1、2、≥3次/年)分组。

主要发现

  • 频繁急性加重是未来急性加重频率的最强预测因素。
  • 基线年加重1次、2次、≥3次者未来急性加重的发生率比分别为1.73(95%CI 1.47-2.02;P<0.0001)、3.14(95%CI 2.70-3.66;P<0.0001)、5.97(95%CI 5.27-6.78;P<0.0001)。
  • 未来急性加重频率的其他独立预测因素包括流感嗜血杆菌和铜绿假单胞菌感染、FEV1、影像学疾病严重度及合并慢性阻塞性肺疾病。
  • 频繁急性加重者生活质量更差,随访期间更可能住院。
  • 随访长达5年期间,死亡率随急性加重频率增加而升高。

临床怎么用

  • 可将年急性加重频率作为支气管扩张症风险分层和随访管理的核心指标。
  • 对频繁急性加重者应加强监测,关注住院和生活质量下降风险。
  • 合并流感嗜血杆菌或铜绿假单胞菌感染、FEV1下降、影像学严重及合并慢阻肺者需警惕未来频繁加重。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE: Exacerbations are key events in the natural history of bronchiectasis, but clinical predictors and outcomes of patients with frequently exacerbating disease are not well described. OBJECTIVES: To establish if there is a "frequent exacerbator phenotype" in bronchiectasis and the impact of exacerbations on long-term clinical outcomes. METHODS: We studied patients with bronchiectasis enrolled from 10 clinical centers in Europe and Israel, with up to 5 years of follow-up. Patients were categorized by baseline exacerbation frequency (zero, one, two, or three or more per year). The repeatability of exacerbation status was assessed, as well as the independent impact of exacerbation history on hospitalizations, quality of life, and mortality. MEASUREMENTS AND MAIN RESULTS: A total of 2,572 patients were included. Frequent exacerbations were the strongest predictor of future exacerbation frequency, suggesting a consistent phenotype. The incident rate ratios for future exacerbations were 1.73 (95% confidence interval [CI], 1.47-2.02; P < 0.0001) for one exacerbation per year, 3.14 (95% CI, 2.70-3.66; P < 0.0001) for two exacerbations, and 5.97 (95% CI, 5.27-6.78; P < 0.0001) for patients with three or more exacerbations per year at baseline. Additional independent predictors of future exacerbation frequency were Haemophilus influenzae and Pseudomonas aeruginosa infection, FEV1, radiological severity of disease, and coexisting chronic obstructive pulmonary disease. Patients with frequently exacerbating disease had worse quality of life and were more likely to be hospitalized during follow-up. Mortality over up to 5 years of follow-up increased with increasing exacerbation frequency. CONCLUSIONS: The frequent exacerbator phenotype in bronchiectasis is consistent over time and shows high disease severity, poor quality of life, and increased mortality during follow-up.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Chalmers JD, Aliberti S, Filonenko A, et al. Characterization of the "Frequent Exacerbator Phenotype" in Bronchiectasis. Am J Respir Crit Care Med. 2018. PMID: 29357265. doi:10.1164/rccm.201711-2202OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。